Compare UnitedHealth Group Inc (UNH) vs Vanguard Total International Stock Index Fund ETF (VXUS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
UnitedHealth Group Inc vs Vanguard Total International Stock Index Fund ETF — how do they compare? UnitedHealth Group Inc trades at $379.3 (market cap $332.96B), while Vanguard Total International Stock Index Fund ETF trades at $84.82 (market cap $665.70B). The key difference: Vanguard Total International Stock Index Fund ETF is the larger of the two by market cap, and UnitedHealth Group Inc pays a 2.5% dividend while Vanguard Total International Stock Index Fund ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold UnitedHealth Group Inc for 97 Days and Vanguard Total International Stock Index Fund ETF for 55 Days on average.
| UNH | VXUS | |
|---|---|---|
Market Cap | $332.96B | $665.70B |
Volume | 7,273,749 | 4,864,744 |
Sector | Health | Sector/Thematic |
52-Week High | $436.35 | $88.41 |
52-Week Low | $259.02 | $72.17 |
Typical Hold Time | 97 Days | 55 Days |
Enterprise Value | $374.82B | — |
Dividend Yield | 2.5% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
UnitedHealth Group (UNH) trades at $370.95, down 1.34% on the day, amid a bearish technical signal from moving averages. The company reported strong Q2 2026 earnings, beating estimates with EPS of $6.38 versus $4.91 expected, and raised full-year guidance. Revenue for 2025 reached $447.57 billion, though net income margin declined to 2.69%. Analyst consensus remains strongly bullish with an 82.69% buy rating and a $470.11 price target, suggesting significant upside from current levels.
UNH presents a compelling investment case driven by earnings beats, raised 2026 outlook, and strategic initiatives like AI investment in Optum. Key risks include regulatory pressures in healthcare, volatility from Medicare Advantage plan changes, and margin compression. The stock's valuation at a P/E of 23.84 appears reasonable given growth prospects, but investors should weigh execution risks against the positive analyst sentiment and institutional backing.
VXUS trades at $84.1, down 0.8% on the day, with a bearish technical signal from moving averages and oscillators. The ETF provides broad international stock exposure, excluding the U.S., and is highlighted in financial media for its diversification benefits and low expense ratio. Recent institutional buying includes positions from QRG Capital Management and Baird Financial Group.
The outlook for VXUS is supported by long-term global diversification themes, but near-term technical weakness and reliance on non-U.S. economic conditions pose risks. Investors seeking international market exposure may find value, though currency fluctuations and regional volatility could impact returns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About UnitedHealth Group Inc
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →About Vanguard Total International Stock Index Fund ETF
VXUS is a comprehensive, low-cost ETF that tracks the FTSE Global All Cap ex US Index, providing exposure to over 8,500 stocks in both developed and emerging markets outside the United States. It serves as a foundational building block for international diversification, allowing investors to own a market-cap-weighted slice of the entire non-U.S. investable equity universe in a single vehicle.
Read more on VXUS →
